Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPOR
101
DELISTED
Gulfport Energy Corp.
GPOR
| $92.1M | 0.18% |
3,104,285
+1,030,093
| +50% | +$35.5M |
|
102
Illumina
ILMN
$33.1B
| $92.1M | 0.18% |
538,217
+74,492
| +16% | +$15.1M |
|
|
SRC
103
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $91.8M | 0.18% |
2,240,094
-219,374
| -9% | -$9.71M |
|
104
Darling Ingredients
DAR
$10.4B
| $90.9M | 0.18% |
8,091,494
+5,190,806
| +179% | +$66.3M |
|
|
QEP
105
DELISTED
QEP RESOURCES, INC.
QEP
| $90.8M | 0.18% |
7,250,617
+3,346,847
| +86% | +$46.2M |
|
|
VMRK
106
Vivmark Residential
VMRK
$25B
| $90.7M | 0.18% |
1,207,737
-15,871
| -1% | -$1.17M |
|
107
Lincoln National
LNC
$8.07B
| $90.2M | 0.17% |
1,901,077
+1,656,472
| +677% | +$88.8M |
|
108
Molson Coors Class B
TAP
$8.01B
| $89.8M | 0.17% |
1,081,888
-386,668
| -26% | -$28M |
|
109
Altria Group
MO
$110B
| $89.7M | 0.17% |
1,649,621
+1,251,806
| +315% | +$67.1M |
|
|
MDCO
110
DELISTED
Medicines Co
MDCO
| $89.6M | 0.17% |
2,359,573
+2,022,837
| +601% | +$71M |
|
111
H&R Block
HRB
$6.62B
| $89.5M | 0.17% |
2,471,491
+1,221,657
| +98% | +$41.4M |
|
|
PDCE
112
DELISTED
PDC Energy, Inc.
PDCE
| $89.1M | 0.17% |
1,681,605
+1,013,178
| +152% | +$51.9M |
|
113
Southwest Airlines
LUV
$19.8B
| $88.6M | 0.17% |
2,330,418
-673,229
| -22% | -$24.8M |
|
114
Coca-Cola
KO
$392B
| $87.5M | 0.17% |
2,181,905
+363,719
| +20% | +$14.6M |
|
115
Advance Auto Parts
AAP
$2.57B
| $87.3M | 0.17% |
460,585
+400,668
| +669% | +$69.4M |
|
|
K
116
DELISTED
Kellanova
K
| $86.9M | 0.17% |
1,390,774
-108,522
| -7% | -$6.77M |
|
117
Netflix
NFLX
$331B
| $86M | 0.17% |
8,331,680
-1,277,220
| -13% | -$13.7M |
|
118
Xylem
XYL
$26.5B
| $85.4M | 0.17% |
2,600,094
+1,200,511
| +86% | +$40.4M |
|
119
VF Corp
VFC
$5.65B
| $85.1M | 0.16% |
1,324,869
-798,997
| -38% | -$54.7M |
|
120
Citigroup
C
$221B
| $84.1M | 0.16% |
1,694,691
-1,275,430
| -43% | -$69.7M |
|
|
NUVA
121
DELISTED
NuVasive, Inc.
NUVA
| $83.9M | 0.16% |
1,739,875
-269,425
| -13% | -$13.9M |
|
122
Citizens Financial Group
CFG
$29.4B
| $83.5M | 0.16% |
3,499,083
+3,107,506
| +794% | +$79.4M |
|
123
Cognizant
CTSH
$27.9B
| $83.2M | 0.16% |
1,328,159
+107,289
| +9% | +$6.73M |
|
|
GGP
124
DELISTED
GGP Inc.
GGP
| $82.7M | 0.16% |
3,183,523
+79,835
| +3% | +$2.1M |
|
125
Pinnacle West Capital
PNW
$11.8B
| $82.6M | 0.16% |
1,288,302
-1,662,914
| -56% | -$102M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.